Wonder semaglutide pill Wegovy arrives in Australia offering patients a needle-free alternative to a weight-loss jab
Here’s what doctors, pharmacists and patients are saying.
The Wegovy weight-loss pill will be available on private prescription from Friday, with a western Sydney chemist among the first in Australia to receive stock. 7NEWS was there as the first boxes were unpacked at Chemistworks in Wetherill Park.
WATCH THE ABOVE VIDEO:
The daily tablet contains semaglutide, the same active ingredient as the weekly Wegovy jab. It mimics a hormone released by the gut after eating and helps regulate appetite.
Sign up to The Nightly's newsletters.
Get the first look at the digital newspaper, curated daily stories and breaking headlines delivered to your inbox.
By continuing you agree to our Terms and Privacy Policy.Pharmacist Catherine Bronger said many patients had been asking when a tablet would arrive.
“I expect that all community pharmacies should have it by tomorrow. or over the weekend. And this is so exciting for patients,” she told 7NEWS.
“We just know that some of the patients are really hesitant when it comes to injecting themselves with the medication.”

Good news for Suzanne
Suzanne Cairns, 50, had been thinking about picking up the tablets in Scotland, where she’s spending Christmas with family.
On Thursday, she got a prescription in Sydney.
“I’ve creeped up in weight since I turned 40, gaining 17 kilos,” Cairns said.
“I wasn’t expecting to get it in Australia before I left, but good news, it’s here.”

How does it compare with the jab?
In separate clinical trials, adults taking the highest tablet dose lost about 14 per cent of their body weight on average over one year.
Those on the standard 2.4mg weekly injection lost about 15 per cent over 68 weeks. The pill is approved for weight management in adults with a body mass index (BMI) of 30 or above, or 27 or above with at least one weight-related health condition.
It’s prescribed alongside dietary changes and increased physical activity, with the dose increased gradually under medical supervision.
Sydney GP Dr Anjali Didi said regular appointments help patients manage side effects and review their dose. “The current advice is that the side effects are similar to the injectables,” she said.
Nausea, vomiting and diarrhoea were among the most commonly reported side effects in the tablet trial. Pancreatitis, or inflammation of the pancreas, is a more serious risk.
How much will it cost?
Novo Nordisk’s recommended price for a month’s supply is $260 for the starting dose, $270 for the 4mg dose, $280 for the 9mg dose and $395 for the highest dose.
The tablet is being launched without a Pharmaceutical Benefits Scheme subsidy, so patients will pay the full pharmacy price.
Catherine Bronger told 7NEWS stock may take several days to reach some pharmacies.
“There will be varying prices depending on what pharmacy you go to and varying availability over the next week.”
Originally published on 7NEWS
